Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 734 across all filing types
Latest filing 2026-05-22 Major Shareholding Noti…
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is a detailed disclosure of large shareholdings by a reporting entity and its related parties, including share counts, percentages, changes, and contract details. It is clearly a regulatory report on significant share ownership and changes thereof, consistent with a Major Shareholding Notification. It is not a board change, earnings release, or meeting material, but a threshold-crossing shareholding report (주식등의 대량보유상황보고서).
2026-05-22 Korean
주요사항보고서(전환사채권발행결정)(자회사의 주요경영사항)
Capital/Financing Update Classification · 87% confidence The document is a regulatory notification (‘주요사항보고서 / 거래소 신고의무 사항’) filed with the Financial Services Commission/Korea Exchange reporting the decision to issue KRW 10 billion of private‐placement convertible bonds. It details the terms of the bond issuance, use of proceeds, conversion terms, and related financing arrangements. This constitutes an update on the company’s financing activity, fitting the Capital/Financing Update category.
2026-05-21 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 95% confidence The document is a "Major Event Report" (주요사항보고서) regarding the company's decision to issue convertible bonds (“전환사채권 발행결정”), detailing issuance amount, interest schedule, maturity, conversion terms, put options, use of proceeds, and regulatory compliance under securities issuance rules. This is clearly a financing/capital-raising announcement rather than an actual financial report, AGM materials, management change, or dividend notice. It falls under the category of Capital/Financing Update.
2026-05-21 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is clearly the full quarterly report (“분기보고서”) for the first quarter of the 56th fiscal period (2026.01.01–2026.03.31) for Aprogen Co., Ltd. It contains comprehensive financial data, corporate overview, detailed tables, historical changes, and other substantive disclosures typical of an interim/quarterly report rather than a simple announcement or summary. Therefore, it should be classified as an Interim / Quarterly Report. Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a ‘주식등의 대량보유상황보고서(일반)’, a large shareholding report filed under Korea’s Capital Markets Act detailing the number and percentage of shares held by a major shareholder and related parties, changes in holdings, and reasons for change. It is not an earnings release, management change, or AGM material but clearly a notification of significant share ownership changes. This matches the ‘Major Shareholding Notification’ category.
2026-05-15 Korean
[기재정정]주요사항보고서(유상증자결정)(자회사의 주요경영사항) (제3자배정)
Share Issue/Capital Change Classification · 90% confidence The document is a correction (“정정신고”) to a previously filed major disclosure (“주요사항보고서(유상증자결정)”) concerning a third-party allotment rights issue (new share issuance). It details the number of shares, issue price, allotment method, schedule, and purpose of proceeds – i.e., a capital structure change via share issuance. This corresponds to the “Share Issue/Capital Change” category (Code: SHA).
2026-05-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.